Long-Term Safety and Antihypertensive Effects of Renal Denervation: Current Insights

Area of Science:

• Cardiology
• Interventional Cardiology
• Nephrology

Background:

• Hypertension is a leading modifiable risk factor for cardiovascular disease globally.
• Despite its significance, widespread blood pressure control remains challenging, with worsening trends in some regions.
• Key barriers include medication non-compliance and therapeutic inertia, alongside patient awareness and healthcare access issues.

Purpose of the Study:

• To review the long-term effectiveness and safety data of various renal denervation (RDN) modalities.
• To assess the durability of blood pressure reduction achieved by RDN.
• To inform the potential for broad clinical implementation of RDN.

Main Methods:

• Systematic review of published long-term data from renal denervation trials.
• Analysis of sham-controlled studies demonstrating the efficacy of RDN.
• Evaluation of safety profiles across different RDN techniques.

Main Results:

• Early trials showed mixed results, but subsequent well-designed studies confirm significant blood pressure lowering effects of RDN.
• Available long-term data indicate that the blood pressure-lowering effects of RDN are durable.
• RDN procedures have demonstrated a favorable safety profile in extensive clinical investigations.

Conclusions:

• Renal denervation is a safe and effective minimally invasive treatment for hypertension.
• The durability of blood pressure reduction supports the potential for RDN in routine clinical practice.
• Further research and long-term follow-up will solidify RDN's role in managing resistant hypertension.